3i is purchasing Alpharma's API business for $395m. Alpharma will invest in its pharmaceutical and animal health divisions. Private equity group, 3i, sees continued growth in serving the generics business built by Alpharma.
In-Pharma Technologist
Thursday, 7 February 2008
3i buys Alpharma API biz
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment